Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study

Nina Paulshus Sundlisæter; Ulf Sundin; Anna-Birgitte Aga; Joseph Sexton; Hilde Berner Hammer; Till Uhlig; Tore K Kvien; Espen A Haavardsholm; Siri Lillegraven

doi:10.1136/rmdopen-2021-002013

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Rheumatoid arthritis

Short report

Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Paulshus Sundlisæter N, Sundin U, Aga A, et al

Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study

RMD Open 2022;8:e002013. doi: 10.1136/rmdopen-2021-002013

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password